Sedation for pharyngeal examination with transoral endoscopy: a comparative study of no sedation, midazolam and pethidine hydrochloride

Sedation for pharyngeal examination with transoral endoscopy: a comparative study of no sedation, midazolam and pethidine hydrochloride - Sedation for pharyngeal examination with transoral endoscopy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000016722

Enrollment

120

Registered

2015-03-06

Start date

2015-03-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pharyngeal cancer

Interventions

no sedation midazolam pethidine hydrochloride

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with esophageal cancer or patients who have history of esophageal cancer

Exclusion criteria

Exclusion criteria: Patients with pharyngeal cancer or patients who have history of pharyngeal cancer Patients with hematological abnormality Patients with severe organ failure Patients who have been judged as in appropriate for this study

Design outcomes

Primary

Measure	Time frame
The score of suitable quality images at the 5 points as follows: uvula, posterior wall of oropharynx, epiglottic vallecula, right pyriform sinus and left pyriform sinus	—

Secondary

Measure	Time frame
Pharyngeal observation time, Visual analogue scale score for discomfort after the pharyngeal examination	—

Countries

Japan

Contacts

Public ContactYasushi Yamasaki

Osaka Medical Center for Cancer and Cardiovascular Diseases Department of Gastrointestinal Oncology

yasshifive@yahoo.co.jp06-6972-1181

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026